Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells

Biochemical and Biophysical Research Communications

Volumn 275, Issue 3, 2000, Pages 746-751

  Romiti, Elena ^a   Meacci, Elisabetta ^a   Tani, Motohiro ^b   Nuti, Francesca ^a   Farnararo, Marta ^a   Ito, Makoto ^b   Bruni, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Acid ceramidase; Endothelial cells; Neutral alkaline ceramidase

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; BRADYKININ; BREFELDIN A; CYCLOHEXIMIDE; DACTINOMYCIN; INTERLEUKIN 1BETA; PHORBOL 13 ACETATE 12 MYRISTATE; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SPECIFICITY; GOLGI COMPLEX; HYDROLYSIS; LIPID METABOLISM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0034618754     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3370     Document Type: Article

References (30)

1. Functions of ceramide in coordinating cellular responses to stress
2. Signal transduction through lipid second messengers
3. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide
4. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
5. Purification, characterization, and biosynthesis of human acid ceramidase
6. Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease
7. Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase
8. Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain
9. Purification and characterization of a neutral ceramidase from mouse liver
10. Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase
11. Molecular cloning and characterization of a human mitochondrial ceramidase
12. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines
13. Bimodal regulation of ceramidase by interleukin-1β
14. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins
15. Sphingomyelin metabolites in vascular cell signaling and atherogenesis
16. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene
17. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development
18. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets
19. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling
20. Enzymatic synthesis of omega-amino-ceramide: Preparation of a sensitive fluorescent substrate for ceramidase
21. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
22. Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa
23. Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae
24. Brefeldin A inhibits the formation of constitutive secretory vesicles and immature secretory granules from the trans-Golgi network
25. Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide
26. Modulation of the transport of a lysosomal enzyme by PDGF
27. Bradykinin increases ceramide and sphingosine content in human fibroblasts: Possible involvement of glycosphingolipids
28. Calcium-independent activation of endothelial nitric oxide synthase by ceramide
29. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells
30. Molecular responses of endothelial tissue to kinins